摘要
目的观察BILT型生物信息红外肝病治疗仪(BILT肝病治疗仪)配合抗乙肝病毒治疗乙型肝炎肝硬化对患者的血小板及参数与凝血指标的影响。方法选择乙型肝炎肝硬化患者分为:联合治疗组46例,在常规保肝及抗病毒治疗的基础上加用BILT肝病治疗仪照射肝区;对照组35例,仅予常规保肝及抗病毒治疗。检测2组患者治疗前、治疗后2周及治疗4周的血小板及参数,凝血酶原时间(PT)、纤维蛋白原(FBG)及抗凝血酶Ⅲ(AT-Ⅲ)的变化。结果与对照组比较,联合治疗组的血小板平均体积(MPV)、FBG、AT-Ⅲ活性(%)均有明显增加,PT缩短,差异有统计学意义(P<0.05)。结论BILT肝病治疗仪有助于改善肝硬化患者凝血机制异常,改善患者的预后。
Objective To observe the affection of antivirus treatment combined with BILT hepatosis therapeutic instrument treatment on platelet parameter and coagulation indicatrix in hepatitis B patients with liver cirrhosis. Methods 81 cases with liver cirrhosis induced by hepatitis B were divided into two groups ： the control group was treated by anti-viral therapy together with some routine treatment ,while the combined treatment group by BILT hepatosis therapeutic instrument treatment （hypochondrium irradiation） based on the treatment as the control group. The platelet parameter, prothrombin time （ PT）, fibrinogen （FBG） and antithrombin Ⅲwere detected 2 weeks before,2 and 4 weeks after the treatment. Results After treatment the total efficacy rate of the combined treatment group Was significantly higher than that of the control group, mean blood platelet volume （MPV）, FBG an（t AT- m of the patients were markedly lifted, PT was significantly reduced （ P 〈 0.05 ）. Conclusions BILT hepatosis therapeutic instrument treatment is effective in treating liver cirrhosis induced by hepatitis B. It can improve the coagulation status and the clinic prognosis of patients with liver cirrhosis.
出处
《中华全科医学》
2008年第10期999-1000,共2页
Chinese Journal of General Practice
关键词
肝硬化
乙型肝炎
血小板参数
凝血因子
肝病治疗仪
Liver Cirrhosis
Hepatitis B
platelet Parameter
Coagulation indicatrix
Hepatosis therapeutic instrument
